Risk Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
Short Title: VIIP Last Published:  06/02/17 12:12:07 PM (Central)
Element: Human Health Countermeasures (HHC)
Evidence:  Report
Risk Master Logic Diagram:  Not Available
Point of Contact:  Michael Stenger
Risk Ratings and Dispositions per Design Reference Mission (DRM) Category
DRM CategoriesMission
Duration
OperationsLong-Term Health
LxCRisk Disposition *LxCRisk Disposition *
Low Earth Orbit6 months3x2To Be Determined3x2To Be Determined
1 year3x2To Be Determined3x3To Be Determined
Deep Space Sortie1 month3x2To Be Determined3x1To Be Determined
Lunar Visit/
Habitation
1 year3x2To Be Determined3x3To Be Determined
Deep Space
Journey/Habitation
1 year3x4To Be Determined3x4To Be Determined
Planetary3 years3x4To Be Determined3x4To Be Determined
Note: LxC is the likelihood and consequence rating. Risk Dispositions are under review by the HSRB.
Risk Statement
Given that the microgravity environment causes cephalad fluid shift in astronauts, there is a probability that astronauts will have intracranial hypertension (IHT) to some degree, and if left untreated, could lead to deleterious health effects.
Gaps (4)